Seminars in Nuclear Medicine

Article	Citations
Theranostics in Lung Neuroendocrine Tumors	168
Neurological Disorders and Women's Health: Contribution of Molecular Neuroimaging Techniques	126
Letter from the Editors	79
PET/CT in the Imaging of CNS Tumors	74
New targets of PET imaging for renal cancer	65
The Value of FDG PET/CT in Penile Cancer: An Update	59
Radioimmunotherapy of Non-Hodgkin B-cell Lymphoma: An update	57
Non-FDG hypoxia tracers	57
Highlighting New Research Trends on Zirconium-89 Radiopharmaceuticals Beyond Antibodies	46
FAPI-PET in Cardiovascular Disease	46
New Promising Targets for Imaging in Cardiovascular Diseases	45
Imaging of Invasive Fungal Infections- The Role of PET/CT	44
Sentinel Lymph Node Methods in Breast Cancer	43
Autoimmune Thyroid Diseases	43
Letter from the Editors	40
Artificial Intelligence for Drug Discovery: An Update and Future Prospects	40
The Role of Nuclear Medicine in Benign Thyroid Disease	39
Controversies in the Radioiodine Treatment of Patients With Differentiated Thyroid Cancer	39
Imaging for Radiation Planning in Breast Cancer	39
Selective Internal Radiotherapy in Liver Tumors: Early Promise Yet to be Fulfilled	39
Prognostic Value of PSMA PET/CT in Prostate Cancer	38
Pediatric Nephro-Urology: Overview and Updates in Diuretic Renal Scans and Renal Cortical Scintigraphy	37
Molecular Imaging in Inflammatory Bowel Disease	37
CD70-Targeted Radiotheranostics: Now and Future	37
Radionuclide Imaging of Cardiac Amyloidosis: An Update and Future Aspects	35

Emerging Trends in Radionuclide Imaging of Infection and Inflammation in Pediatrics: Focus on FDG PET/CT and Immune Reactivity	33
Global experience in brain amyloid imaging	33
Total-Body PET/CT: A Role of Artificial Intelligence?	33
The Evolution of Artificial Intelligence in Nuclear Medicine	32
PET-CT radiomics for immunotherapy response	31
New Approaches for Imaging Bacteria	30
Current and Future Perspective of PET/CT in Response Assessment of Malignant Pleural Mesothelioma	30
The Role of 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (18F-FDG PET/CT) in the Diagnosis and Evaluation of Spondylodiscitis	29
Remote Reading and Teaching of Nuclear Medicine in the Era of COVID-19	29
Imaging of Cardiac Sarcoidosis: An Update and Future Aspects	27
Expanding Role for Gallium-68 PET Imaging in Oncology	25
The value of PSMA PET for risk stratification in prostate cancer: an update and future aspects	25
Artificial intelligence for tumor [18F]FDG-PET imaging: Advancement and future trends—part I	25
18F-Fluoride PET/CT—Updates	25
PET/MR Technology: Advancement and Challenges	25
Total Body Positron Emission Tomography/Computed Tomography: Current Status in Oncology	24
Use of Radionuclide-Based Imaging Methods in Breast Cancer	24
Letter From the Editors	23
Renography: Methods and Pitfalls	23
Scintigraphic Diagnosis of Acute Pulmonary Embolism: From Basics to Best Practices	23
Update on Pediatric Nuclear Medicine in Acute Care	23
Fibroblast Activation Protein Inhibitor (FAPI) PET Imaging in Sarcomas: A New Frontier in Nuclear Medicine	21
The Clinical Impact of FAPI PET Imaging: HCC, CCC, CUP & Peritoneal Carcinoma	21
Total-body PET/CT – First Clinical Experiences and Future Perspectives	21
18F-Sodium Fluoride PET/CT in Assessing Valvular Heart and Atherosclerotic Diseases	20
FDG PET/CT for Staging Lung Carcinoma: An Update	20
Standardized PSMA-PET Imaging of Advanced Prostate Cancer	20
Nuclear Medicine Preclinical Research: The Role of Cell Cultures	20
Recent Advances and Future Trends of[18F]-Labeled PET Agents for Renal Imaging	19
Future Imaging of Prostate Cancer: Do We Need More Than PSMA PET/CT?	19
Impact of COVID-19 on Nuclear Medicine in Asia	19
Therapy strategies to defeat prostate cancer heterogeneity	19
Radiolabeled Somatostatin Analogs for Cancer Imaging	19
FAPI PET Versus FDG PET/CT in Gastrointestinal Cancers: An Overview	19
Practice of 18F-FDG-PET/CT in ICU Patients: A Systematic Review	19
Artificial Intelligence Augmented Cerebral Nuclear Imaging	18
Targeted Radiopharmaceutical Therapy for Bone Metastases	18
Functional Imaging of Testicular Torsion	18
The Impact of PSMA PET/CT Imaging in Prostate Cancer Radiation Treatment	18
Safe Pulmonary Scintigraphy in the Era of COVID-19	18
The Clinical Utility of Molecular Imaging in COVID-19: An Update	18
Advances in PET Imaging of Large Vessel Vasculitis: An Update and Future Trends	17
Optimizing CT Imaging Parameters: Implications for Diagnostic Accuracy in Nuclear Medicine	17
Artificial Intelligence and Workforce Diversity in Nuclear Medicine	16
The Impact of COVID-19 on Nuclear Medicine in Europe	16
Molecular Imaging in Soft-tissue Sarcoma: Evolving Role of FDG PET	16
Academic integrity and artificial intelligence: is ChatGPT hype, hero or heresy?	16
Sentinel Node Mapping in Penile Cancer: An Update on Methods and Pitfalls	16
Nonmalignant findings on FAPI PET: An updated rapid systematic review of the literature	16
Recent Advances in Radiopharmaceutical Theranostics of Pheochromocytoma and Paraganglioma	16

Application of Artificial Intelligence in Oncologic Molecular PET-Imaging: A Narrative Review on Beyond [18F]F-FDG Tracers Part II. [F]F-FLT, [F]F-FET, [C]C-MET and Other Less-Commonly Used Radiotrace	16
Total-Body PET/CT Metabolic Response in Esophageal Squamous Cell Carcinoma	16
Radiomics and Artificial Intelligence Landscape for [18F]FDG PET/CT in Multiple Myeloma	15
Telehealth in Multidisciplinary Target Delineation for Radiotherapy During the COVID-19 Pandemic. A Review and a Case	15
Quantitative SPECT/CT for Dosimetry of Peptide Receptor Radionuclide Therapy	15
Development of PSMA-Targeted Alpha Therapy Using [211At]PSMA-5	15
A Role of Non-FDG Tracers in Lung Cancer?	15
Letter from the Editors	15
Molecular Imaging for Response Assessment of Neuroendocrine Tumors (NET)	15
Letter From the Guest Editors	14
FDG-PET/CT of COVID-19 and Other Lung Infections	14
RETRACTED: Radiotracing the Future: Non-FDG Radiotracers Nuclear Medicine	14
Neuroimaging of Mild Traumatic Injury	14
Infection and Inflammation in Nuclear Medicine Imaging: The Role of Artificial Intelligence	14
Current Developments on [18F]FDG PET/CT in Inflammatory Disorders of the Central Nervous System	14
Prostate Cancer Theranostics With 177Lu-PSMA	14
COVID-19 Pandemic: What Have We Learned and What to Expect in the Future?	14
Radiolabeled Antibody–Drug Conjugates in the Treatment of Solid Tumors	14
Radiomolecular Theranostics With Fibroblast-Activation-Protein Inhibitors and Peptides	14
Letter From the Editors	14
Radiation Dose to Pediatric Patients From Radiopharmaceuticals	13
A Practical Guide to the Pearls and Pitfalls of PSMA PET Imaging	13
Letter from the Editors	13
Hybrid Imaging: Calcium Score and Myocardial Perfusion Imaging	13
How to Perform FAPI PET? An Expedited Systematic Review Providing a Recommendation for FAPI PET Imaging With Different FAPI Tracers	13
Advances in PET/CT Technology: An Update	13
Cardiac PET/MRI: Recent Developments and Future Aspects	13
Response Evaluation Criteria in Grade 1/2 Neuroendocrine Tumors (RECIN)	13
Total Body PET/CT: A Role in Musculoskeletal Diseases	12
Parathyroid Imaging	12
Towards a More Inclusive Future: A Comprehensive Assessment of Gender Diversity in Nuclear Medicine Education, Training and Workforce	12
Letter from the Editors	12
Letter from the Editors	12
Cardiovascular Imaging in Women	12
PET/CT Assessment of Estrogen Receptor positivity for Breast Cancer using [68Ga]Ga-RM2 Bombesin Receptor Antagonist: A Systematic Review and Meta-Analysis	12
Advances of PET/CT in Target Delineation of Lung Cancer Before Radiation Therapy	12
Letter From the Editors	11
Preclinical Evaluation of Novel PET Probes for Dementia	11
Copper-64 Based PET-Radiopharmaceuticals: Ways to Clinical Translational	11
Response assessment in advanced differentiated thyroid cancer	11
SPECT/CT, PET/CT, and PET/MRI for Response Assessment of Bone Metastases	11
Dosimetric Approaches for Radioimmunotherapy of Non-Hodgkin Lymphoma in Myeloablative Setting	11
The Value of Artificial Intelligence in Prostate-Specific Membrane Antigen Positron Emission Tomography: An Update	10
FDG PET/CT for Staging and Restaging Malignant Mesothelioma	10
Letter from the Editors	10
Long Axial Field-of-View PET/CT: New Opportunities for Pediatric Imaging	10
New PET Tracers: Current Knowledge and Perspectives in Lung Cancer	10
New Targets for Imaging in Nuclear Medicine	10
Insights into the Global Practice of Paediatric Renal Scintigraphy Studies	10
Current and Future Perspectives of PDL1 PET and SPECT Imaging	9
Clinical Management of COVID-19 Patients – An Update	9
Advancement and Future Perspective of FAPI PET/CT In Gynecological Malignancies	9
Diagnosing Bone Metastases in Breast Cancer: A Systematic Review and Network Meta-Analysis on Diagnostic Test Accuracy Studies of 2-[18F]FDG-PET/CT, 18F-NaF-PET/CT, MRI, Contrast-Enhanced CT, and Bone	9
Pitfalls of Radionuclide Renal Imaging in Pediatrics	9
Implementation of Radiotheranostics: Challenges, Barriers, and IAEA-Driven Strategies for Sustainable Access	9
New Targets for Positron Emission Tomography Imaging in Parkinson´s Disease	9
Imaging of Endocarditis and Cardiac Device-Related Infections: An Update	9
Hepato-Biliary Imaging in an Acute Setting: Is There a Role for Nuclear Medicine?	9
Glypican-3: Novel Theranostic Agent for Hepatocellular Carcinoma	9
The Past, Present, and Future Role of Artificial Intelligence in Ventilation/Perfusion Scintigraphy: A Systematic Review	9
The Value of FAPI PET/CT in Cholangiocarcinoma and Pancreatic Cancer: An Update	9
Molecular imaging Theranostics of Neuroendocrine Tumors	9
Imaging of Bone Metastases in Breast Cancer	9
AI in SPECT Imaging: Opportunities and Challenges	9
Letter from the Editors	8
Preclinical Development in Radiopharmaceutical Therapy for Prostate Cancer	8
FDG PET/CT Imaging of Sarcoidosis	8
Letter From the Editors	8
Letter from the Editors	8
Advancement in Production of Radiotracers	8
Application of Deep Learning in Breast Cancer Imaging	8
Imaging Approach to Disease of the Pleura	8
The Role of FDG-PET and Whole-Body MRI in High Grade Bone Sarcomas With Particular Focus on Osteosarcoma	8
Advances in PSMA Alpha Theragnostics	8
The Rebirth of Radioimmunotherapy of Non-Hodgkin Lymphoma: The Phoenix of Nuclear Medicine?	8
Combination Strategies and Targeted Radionuclide Therapies	8
Application of Artificial Intelligence in Oncologic Molecular PET-Imaging: A Narrative Review on Beyond [18F]F-FDG Tracers - Part I. PSMA, Choline, and DOTA Radiotracers	8
Clinical Use of PET/MR in Oncology: An Update	7
Critical Appraisal of the Current Role of Myocardial Perfusion Imaging in the Management of Acute Chest Pain	7
The Impact of Radiopharmaceutical Therapy on Renal Function	7

Renal Scintigraphy in Adults: An Update	7
Role of Artificial Intelligence in PET/CT Imaging for Management of Lymphoma	7
The Current Role of Tau PET Imaging in Neurodegeneration	7
Preclinical Imaging Studies: Protocols, Preparation, Anesthesia, and Animal Care	7
Molecular Imaging of Tuberculosis	7
PET/CT in Bladder Cancer: An Update	7
Total Body PET-CT Protocols in Oncology	7
A Role for PET/CT in Response Assessment of Malignant Pleural Mesothelioma	7
Diagnostic Value of Gastrin-Releasing Peptide Receptor-Targeted PET Imaging in Oncology: A Systematic Review	7
Long Axial Field-of-View (LAFOV) PET/CT in Prostate Cancer	7
FDG-PET/CT for Primary Staging and Detection of Recurrence of Breast Cancer	7
Bone Metastasis in Prostate Cancer: Bone Scan Versus PET Imaging	7
Molecular Imaging of Fever of Unknown Origin: An Update	7
The Role of [18F]FDG PET/CT in Monitoring of Therapy Response in Lung Cancer	7
Letter From the Editors	7
Artificial Intelligence in Nuclear Cardiology: An Update and Future Trends	7
Diuretic Renal Scintigraphy in Adults: Practical Aspects and Reporting	6
Molecular Imaging of Pituitary Tumors	6
Total-Body PET/CT: Pros and Cons	6
Radioactive Iodine Therapy in Differentiated Thyroid Cancer: An Update on Dose Recommendations and Risk of Secondary Primary Malignancies	6
Clinical Value of FDG-PET/CT in Multiple Myeloma: An Update	6
The Role of AI in the Evaluation of Neuroendocrine Tumors: Current State of the Art	6
Impact of PSMA PET on Radiation Oncology Planning	6
How to Report PSMA PET	6
Vulnerable Plaque Imaging	6
The role of non-FDG agents in PET imaging of bladder cancer	6
PET/CT in Hodgkin Lymphoma: An Update	6
18F-FDG PET/CT for Response Assessment in Lung Cancer	6
Present status and future trends in molecular imaging of lymphocytes	6
Mucin-Targeted Antibodies for Ovarian Cancer	6
Potential of Technetium and Rhenium Theranostics	6